Pharmaceutical Drug Dealers in Borivali, Mumbai

• Color: White
• Form: Powder
• Packaging Type: Plastic Packets
• Country of Origin: India
• Speaciality: No Side Effect, Longer Shelf Life, Effectiveness
• Usage: Animals Feed and Veterinary
• Purity: 100 %

• Form: Tablets / Liquid / Capsules / Powder
• Packaging Type: Plastic Bottle
• Usage: Clinical, hospital etc.
• CATEGORY: Anti-Fungal Drugs
• Dosage: 5mg
• Grade Standard: Medicine Grade
• Storage: Cool and Dry Place
• Storage: Cool and Dry Place

DESCRIPTION  Amphotericin B Lipid Complex injection 10,25,50 & 100 mg  is used in treatment of invasive fungal infections in patients refractory to conventional amphotericin B therapy.It act by altering fungal cell membrane permeability by binding to the sterol component of the cell membrane. There are many generic manufacturers in India who manufacture  Amphotericin B Lipid Complex injection10,25,50 & 100 mg including United biotech etc. 3s corporation is Supplier,Exporter ,Wholesaler  for  Amphotericin B Lipid Complex injection 10,25,50 & 100 mg in India.   ADDITIONAL INFORMATION For Systemic Fungal Infections in Adults and Children IV dose of  5 mg/kg/day as a single infusion is given. In case of Renal Function Impairment (CrCl less than 10 mL/min)dose of 5 mg/kg every 24 to 36 h is given. SIDE EFFECTS CARDIOVASCULAR Phlebitis (25%); hypertension, tachycardia (23%); hypotension (22%); chest pain (12%); cardiac arrest (6%); vasodilatation (5%); atrial fibrillation, bradycardia, cardiac arrest, cardiomegaly, hemorrhage, postural hypotension, valvular heart disease, vascular disorder (2% to 10%); cardiovascular disorder (at least 5%); CHF, shock, supraventricular tachycardia, syncope, ventricular extrasystoles (1% to less than 5%); MI, shock, tachypnea. CNS Insomnia (22%); headache (21%); anxiety (14%); asthenia, confusion (13%); dizziness (10%); abnormal thinking, agitation, coma, convulsions, depression, dysesthesia, hallucinations, malaise, nervousness, paresthesia, somnolence, tremor (2% to 10%); hypertonia, neuropathy, psychosis, speech disorder, stupor (1% to less than 5%); cerebral vascular accident, diplopia, encephalopathy, extrapyramidal syndrome, peripheral neuropathy, transient vertigo. DERMATOLOGIC Rash (25%); pruritus, sweating (11%); alopecia, dry skin, herpes simplex, maculopapular rash, purpura, skin discoloration, skin disorder, skin ulcer, urticaria, vesiculobullous rash (2% to 10%); acne, petechial rash, skin nodule (1% to less than 5%); erythema, erythema multiforme, exfoliative dermatitis, flushing. EENT Conjunctivitis, dry eyes, eye hemorrhage, pharyngitis (2% to 10%); amblyopia, deafness, ear disorder, tinnitus (1% to less than 5%); visual impairment. GI Vomiting (44%); nausea (40%); diarrhea (30%); abdominal pain (22%); constipation (21%); anorexia (14%); GI hemorrhage, nausea and vomiting (11%); abdomen enlarged, dry mouth/nose, dyspepsia, dysphagia, eructation, fecal incontinence, flatulence, hemorrhoids, gum/oral hemorrhage, hematemesis, ileus, mucositis, rectal disorder, stomatitis, ulcerative stomatitis (2% to 10%); bloody diarrhea, GI disorder, gingivitis, glossitis, increased GGT, melena, mouth ulceration, oral moniliasis, rectal disorder (1% to less than 5%); cramping, epigastric pain. GENITOURINARY Nephrotoxicity (63%); hematuria (14%); kidney failure (5%); abnormal renal function, acute kidney failure, acute renal failure, dysuria, toxic nephropathy, urinary incontinence, vaginal hemorrhage (2% to 10%); albuminuria, glucosuria, oliguria, urinary retention, urinary tract disorder (1% to less than 5%); anuria, azotemia, decreased renal function, hemorrhagic cystitis, hyposthenuria, impotence, nephrocalcinosis, renal tubular acidosis. HEMATOLOGIC-LYMPHATIC Anemia (48%); leukopenia (17%); thrombocytopenia (13%); coagulation disorder, decreased or increased prothrombin, ecchymosis, fluid overload, petechiae (2% to 10%); decreased thromboplastin, hypochromic anemia, increased fibrinogen, leukocytosis (1% to less than 5%); blood dyscrasias including coagulation defects, eosinophilia, normochromic or normocytic anemia; agranulocytosis (postmarketing). HEPATIC Bilirubinemia (19%); increased ALT (15%); abnormal LFTs, increased AST (13%); hepatocellular damage, hepatomegaly, veno-occlusive liver disease (2% to 10%); jaundice (at least 5%); liver failure (1% to less than 5%); cholangitis, cholecystitis, hepatitis. HYPERSENSITIVITY Allergic reaction (2% to 10%); anaphylactic and anaphylactoid reactions, bronchospasm, hypersensitivity pneumonitis, wheezing. LOCAL Injection-site inflammation (2% to 10%); injection-site pain, injection-site reaction (1% to less than 5%); thrombophlebitis. METABOLIC-NUTRITIONAL Hypokalemia (51%); hypomagnesemia, increased creatinine (49%); increased BUN (31%); hyperglycemia (28%); increased alkaline phosphatase (22%); hypocalcemia (21%); peripheral edema (17%); edema, hypervolemia (15%); hyponatremia (12%); hypernatremia (11%); acidosis, hyperchloremia, hyperkalemia, hypermagnesemia, hyperphosphatemia, hypophosphatemia, hypoproteinemia, increased amylase, increased LDH, increased nonprotein nitrogen, respiratory alkalosis (2% to 10%); weight gain (at least 5%); dehydration, hyperlipidemia, hypoglycemia, weight loss (1% to less than 5%); hyperamylasemia, hyperuricemia. MUSCULOSKELETAL Back pain (12%); arthralgia, bone pain, dystonia, myalgia, neck pain, rigors (2% to 10%); myasthenia including bone, joint, and muscle pain. RESPIRATORY Dyspnea (29%); increased cough (22%); hypoxia (21%); epistaxis (20%); lung disorder (18%); pleural effusion (13%); rhinitis (11%); respiratory failure (8%); apnea (at least 5%); hyperventilation (5%); asthma, atelectasis, hemoptysis, hiccup, lung edema, pneumonia, respiratory insufficiency, sinusitis (2% to 10%); respiratory disorder (1% to less than 5%); bronchospasm, cyanosis/hypoventilation, pulmonary edema (postmarketing). MISCELLANEOUS Chills/rigors (90%); chills (77%); fever (58%); blood product transfusion reaction (19%); pain, sepsis (14%); infection (13%); multiple organ failure (11%); procedural complications (10%); cell-mediated immunological reaction, cellulitis, face edema, graft-versus-host disease, influenza-like symptoms (2% to 10%); chills/fever (7%); mucous membrane disorder (at least 5%); death, hypothermia, immune system disorder (1% to less than 5%); angioedema (postmarketing).

• Form: Tablets
• Packaging Type: Plastic Bottle
• Medicine Type: Allopathic
• Country of Origin: India
• Brand Name: 30 Tablets
• Treatment: Used to Treat HIV Infection
• TL: Lamivudine (300mg) + Tenofovir Disoproxil Fumarate (300mg)
• Generic Name: Tavin L
• Manufactured By: Emcure Pharmaceuticals

Tavin L Tablet is a combination of two anti-HIV medicines: Lamivudine and Tenofovir disoproxil fumarate. They prevent HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.   " Tavin L tablet suppler in Mumbai "

• Form: Liquid
• Packaging Type: Plastic Bottle
• Packaging Size: 100ml
• Strength: 400mg/100ml
• Treatment: Pain-relieving Medicine
• Composition: Ibuprofen Solution
• Medicine Type: Allopathic
• Generic Name: Inzan
• Manufactured By: Hetero Healthcare

acetic acid, Benzoyl Chloride, ACETYL CHLORIDE, Adipic Acid

• Manufactured By: Scindia Pharma
• Strength: mg
• Packaging Size: 10*10 Tablets
• Brand Name: Gabliscin
• Active Ingredients: Gabapentin mg
• Release Form: Oral Tablets

Gabliscin have Gabapentin is an active ingredients which is an anti epileptic drug. It is in an anticonvulsant drug class. Gabapentin is a prescription medication known as a gamma aminobutyric acid (GABA) analogue. GABA reduces the excitability of nerve cells (neurons) in the brain which play a role in seizures and the transmission of pain signals. Gabliscin is a medication primarily used to treat partial seizures and neuropathic pain. It is used in adults and children elder than 3 years have who are suffering from partial seizures. It is also used in shingles that may effective after a long time once had chickenpox. The virus of chickenpox stays in portal in spinal nerve which may effective by stress or any reason causing shingles. It is a first line medication for the treatment of neuropathic pain caused by diabetic neuropathy, Postherpetic neuralgia, and central pain. It is most effective for the treatment of epileptic.   Usage :  Gabliscin is anti-epileptic or anticonvulsant medicine which prevents and control partial seizures. It relieve postherpetic neuralgia as well as moderate to severe restless legs syndrome. It is also used to relieve nerve pain following shingles. This is prescribed medicine which is completely based upon patient’s health conditions and severity. Weight is considered if patient is child.   Warning : <font color="red">Dosage: As directed by the physician</font> <font color="red">Storage: Keep in cool, dark & dry place.</font>   Side Effects: Sleepiness Dry mouth Nausea Vomiting Tiredness Headache Nasopharyngitis Stomachache   <font color="red"><i>Keep medicine out of reach of Children.</i></font>   <font color="#f79a29">FAQ: Gabliscin</font>   Does Gabliscin cause weight gain? Yes, Gabliscin can increase hunger which may affect on weight.   Is Gabliscin can be addictive? No, it cannot be addictive if it is taken as per doctor’s recommendation.   Should I drive while taking Gabliscin? No, Gabliscin makes sleepy so it is not safe to drive.   Can I take alcohol while taking Gabliscin? No, Gabliscin makes sleepy along with alcohol it may cause extreme sleepiness.